Drug Manufacturers, Technology

The Antibody Dependent Cell Mediated Cytotoxicity

By Bioassay

The medical indications of therapeutic antibodies (tAb) have been growing. The antibody dependent cell-mediated cytotoxicity (ADCC) is a mechanism of immune defence attributed to the mode of action of several tAb, in particular, tumour cell targeting.

In ASCC, tumour cells (recognised by tAb) are targeted by natural killer cells by their FcDRlll (CD16) receptor binding to the Fc portion of the tAb followed by lysis of the target (tumour) cell.

Enter your details below to view the free white paper

By downloading this whitepaper, you acknowledge that GlobalData may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.